Kenneth L. Subotnik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kenneth L. Subotnik has a total of 107 co-authors. Here are the top co-authors by number of shared publications:
- Keith H. Nuechterlein
University of California, Los Angeles
23 shared publications - Joseph Ventura
UCLA Department of Psychiatry, Semel Institute for Neuroscience and Human Behavior, 300 Medical Plaza, Room 2243, Los Angeles, CA 90095, USA
17 shared publications Keith H. Nuechterlein
University of California, Los Angeles, USA
10 shared publicationsGerhard S. Hellemann
University of Alabama at Birmingham, USA
7 shared publicationsJoseph Ventura
University of California, Los Angeles, USA
7 shared publications- Denise Gretchen-Doorly
UCLA Aftercare Research Program, Semel Institute for Neuroscience and Human Behavior, Los Angeles, CA, USA
6 shared publications
Latest Publications
- 10 September 2025
- Published by SAGE Publications in Behavior Modification
- Vol. 49 (5-6) , 430-449
Aerobic Exercise Enhances the Impact of Cognitive Training on Positive Symptoms After a First Episode of Schizophrenia
We examined the effects of combining cognitive training plus aerobic exercise versus cognitive training alone on positive symptoms in recent-onset schizophrenia patients. Sixty-eight participants were randomly assigned to Cognitive Training plus Exercise (CT&E, N = 37) or Cognitive Training alone (CT, N = 31). All participants were also randomly assigned to either oral risperidone or paliperidone palmitate (PP1M) in a concurrent antipsychotic medication study. All participants were provided four weekly sessions of internet-based cognitive training conducted in a group format for 6 months, during which half were randomized to receive a 150 min/week aerobic exercise program. Then participants received 6 additional months of treatment at half of the psychosocial intervention frequency. Reality Distortion, the mean of BPRS ratings of Unusual Thought Content and Hallucinations, was averaged over all available BPRSs during the 3-month pre-baseline period and over four 3-month time periods during the 12 months of intervention. The proportion of BPRS administrations wherein either Unusual Thought Content or Hallucinations was rated >4 was used as a measure of breakthrough psychotic symptoms. Reality Distortion significantly decreased over time for the CT&E group compared to the non-Exercise (CT) group, F (4, 208) = 2.9, p = .02. The proportion of BPRS ratings with breakthrough symptoms decreased over successive 3-month periods for the CT&E group compared to the CT group, F (4, 218) = 6.9, p < .0001. The two medication groups did not significantly differ on either positive symptom outcome, and there were no three-way interactions. Our findings suggest that the enhancing effect of adding aerobic exercise to cognitive training extends beyond cognitive gains and includes positive psychotic symptoms.
- 10 September 2025
- Published by SAGE Publications in Behavior Modification
- Vol. 49 (5-6) , 430-449
Aerobic Exercise Enhances the Impact of Cognitive Training on Positive Symptoms After a First Episode of Schizophrenia
We examined the effects of combining cognitive training plus aerobic exercise versus cognitive training alone on positive symptoms in recent-onset schizophrenia patients. Sixty-eight participants were randomly assigned to Cognitive Training plus Exercise (CT&E, N = 37) or Cognitive Training alone (CT, N = 31). All participants were also randomly assigned to either oral risperidone or paliperidone palmitate (PP1M) in a concurrent antipsychotic medication study. All participants were provided four weekly sessions of internet-based cognitive training conducted in a group format for 6 months, during which half were randomized to receive a 150 min/week aerobic exercise program. Then participants received 6 additional months of treatment at half of the psychosocial intervention frequency. Reality Distortion, the mean of BPRS ratings of Unusual Thought Content and Hallucinations, was averaged over all available BPRSs during the 3-month pre-baseline period and over four 3-month time periods during the 12 months of intervention. The proportion of BPRS administrations wherein either Unusual Thought Content or Hallucinations was rated >4 was used as a measure of breakthrough psychotic symptoms. Reality Distortion significantly decreased over time for the CT&E group compared to the non-Exercise (CT) group, F (4, 208) = 2.9, p = .02. The proportion of BPRS ratings with breakthrough symptoms decreased over successive 3-month periods for the CT&E group compared to the CT group, F (4, 218) = 6.9, p < .0001. The two medication groups did not significantly differ on either positive symptom outcome, and there were no three-way interactions. Our findings suggest that the enhancing effect of adding aerobic exercise to cognitive training extends beyond cognitive gains and includes positive psychotic symptoms.
- Open Access
- 14 April 2023
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 53 (14) , 6878-6887
The relationship between sex and functional outcome in first-episode schizophrenia: the role of premorbid adjustment and insight
Background: Studies that examined sex differences in first-episode patients consistently show that males compared to females have poor premorbid adjustment, earlier age of onset, worse clinical characteristics, and poorer outcomes. However, little is known about potential mediators that could explain these sex differences.Methods: Our sample consisted of 137 individuals with first episode schizophrenia (males, n = 105; 77%) with a mean age of 22.1(s.d. = 4.1) years and mean education of 12.5(s.d. = 1.7) years. At entry, patients were within 2 years of their first psychotic episode onset. Baseline assessments were conducted for premorbid adjustment, symptoms, cognitive functioning, insight, and at 6-months for role and social functioning.Results: Males as compared to females had poorer premorbid adjustment across several key developmental periods (p < 0.01), an earlier age of onset [M = 20.3(3.3) v. 22.8(5.6), p = 0.002], more negative symptoms (p = 0.044), poorer insight (p = 0.031), and poorer baseline and 6-month role (p = 0.002) and social functioning (p = 0.034). Several of these variables in which males showed impairment were significant predictors of 6-month role and social functioning. Premorbid adjustment and insight mediated the relationship between sex and role and social functioning at 6-months, but not negative symptoms.Discussion: Males compared to females were at lower levels across several key premorbid and clinical domains which are strongly associated with functional outcome supporting the hypothesis that males might have a more disabling form of schizophrenia. The relationship between sex with role and social functioning was mediated through premorbid adjustment and insight suggesting pathways for understanding why females might have a less disabling form of schizophrenia.
- 14 April 2023
- Published by Cambridge University Press (CUP) in Psychological Medicine
- Vol. 53 (14) , 6878-6887
Open AccessThe relationship between sex and functional outcome in first-episode schizophrenia: the role of premorbid adjustment and insight
Background: Studies that examined sex differences in first-episode patients consistently show that males compared to females have poor premorbid adjustment, earlier age of onset, worse clinical characteristics, and poorer outcomes. However, little is known about potential mediators that could explain these sex differences.Methods: Our sample consisted of 137 individuals with first episode schizophrenia (males, n = 105; 77%) with a mean age of 22.1(s.d. = 4.1) years and mean education of 12.5(s.d. = 1.7) years. At entry, patients were within 2 years of their first psychotic episode onset. Baseline assessments were conducted for premorbid adjustment, symptoms, cognitive functioning, insight, and at 6-months for role and social functioning.Results: Males as compared to females had poorer premorbid adjustment across several key developmental periods (p < 0.01), an earlier age of onset [M = 20.3(3.3) v. 22.8(5.6), p = 0.002], more negative symptoms (p = 0.044), poorer insight (p = 0.031), and poorer baseline and 6-month role (p = 0.002) and social functioning (p = 0.034). Several of these variables in which males showed impairment were significant predictors of 6-month role and social functioning. Premorbid adjustment and insight mediated the relationship between sex and role and social functioning at 6-months, but not negative symptoms.Discussion: Males compared to females were at lower levels across several key premorbid and clinical domains which are strongly associated with functional outcome supporting the hypothesis that males might have a more disabling form of schizophrenia. The relationship between sex with role and social functioning was mediated through premorbid adjustment and insight suggesting pathways for understanding why females might have a less disabling form of schizophrenia.
- 31 March 2023
- Published by Elsevier in Schizophrenia Research
- Vol. 255, 195-202
Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: Magnetic resonance imaging results from the DREaM study
- 31 March 2023
- Published by Elsevier in Schizophrenia Research
- Vol. 255, 195-202
Effect of treatment with paliperidone palmitate versus oral antipsychotics on frontal lobe intracortical myelin volume in participants with recent-onset schizophrenia: Magnetic resonance imaging results from the DREaM study
- Open Access
- 21 January 2023
- Published by MDPI AG in Behavioral Sciences
- Vol. 13 (2) , 88
Exercise Predicts a Good Night’s Sleep: Preliminary Findings from a UCLA Study of First-Episode Schizophrenia
Background: Physical exercise can improve sleep quality in the general population. Understanding the negative impact of poor sleep quality on multiple domains of functioning among persons with schizophrenia is a new frontier of exploration. It is also imperative to investigate non-pharmacologic methods to improve sleep quality as these approaches may not carry the side effect burdens associated with medication. Objective: We examined the relationship between regular physical exercise and sleep quality among participants in an intervention consisting of both cognitive training and exercise. Methods: Participants (N = 48) were schizophrenia patients who had a first psychotic episode within two years of study entry. Participants received 4 h/week of internet-based cognitive training and an aerobic exercise program over a 6-month period. Sleep was assessed with the Pittsburgh Sleep Quality Index at baseline and six months later. Results: During the 3 months prior to the 6-month follow-up sleep assessment, participants completed an average of 12.6 group exercise sessions and an average of 12.9 individual at-home exercise sessions. A significant relationship between the number of exercise sessions and global sleep quality was seen at month six, r = −0.44, df = 39, p < 0.01. Group exercise frequency was also associated with improvement in global sleep quality over the six-month intervention, t(34) = −2.84, p = 0.008. Conclusion: We demonstrated that a group of young adults with schizophrenia can be engaged in a regular exercise program, even during the tumultuous early course of the disorder. The number of exercise sessions in which they participated was associated with better sleep quality at six months and pre–postintervention improvement in sleep quality. Key message: Improved sleep quality appears to be a benefit of regular exercise among individuals with serious mental illness.
- 21 January 2023
- Published by MDPI AG in Behavioral Sciences
- Vol. 13 (2) , 88
Open AccessExercise Predicts a Good Night’s Sleep: Preliminary Findings from a UCLA Study of First-Episode Schizophrenia
Background: Physical exercise can improve sleep quality in the general population. Understanding the negative impact of poor sleep quality on multiple domains of functioning among persons with schizophrenia is a new frontier of exploration. It is also imperative to investigate non-pharmacologic methods to improve sleep quality as these approaches may not carry the side effect burdens associated with medication. Objective: We examined the relationship between regular physical exercise and sleep quality among participants in an intervention consisting of both cognitive training and exercise. Methods: Participants (N = 48) were schizophrenia patients who had a first psychotic episode within two years of study entry. Participants received 4 h/week of internet-based cognitive training and an aerobic exercise program over a 6-month period. Sleep was assessed with the Pittsburgh Sleep Quality Index at baseline and six months later. Results: During the 3 months prior to the 6-month follow-up sleep assessment, participants completed an average of 12.6 group exercise sessions and an average of 12.9 individual at-home exercise sessions. A significant relationship between the number of exercise sessions and global sleep quality was seen at month six, r = −0.44, df = 39, p < 0.01. Group exercise frequency was also associated with improvement in global sleep quality over the six-month intervention, t(34) = −2.84, p = 0.008. Conclusion: We demonstrated that a group of young adults with schizophrenia can be engaged in a regular exercise program, even during the tumultuous early course of the disorder. The number of exercise sessions in which they participated was associated with better sleep quality at six months and pre–postintervention improvement in sleep quality. Key message: Improved sleep quality appears to be a benefit of regular exercise among individuals with serious mental illness.
- 1 December 2021
- Published by Elsevier in Schizophrenia Research
- Vol. 238, 170-177
Confident memory errors and disrupted reality testing in early psychosis
- 1 December 2021
- Published by Elsevier in Schizophrenia Research
- Vol. 238, 170-177
Confident memory errors and disrupted reality testing in early psychosis
- 1 June 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 220, 164-171
Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis
- 1 June 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 220, 164-171
Relationship of poor insight to neurocognition, social cognition, and psychiatric symptoms in schizophrenia: A meta-analysis
- 1 April 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 218, 233-239
Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia
- 1 April 2020
- Published by Elsevier in Schizophrenia Research
- Vol. 218, 233-239
Associations between physiological responses to social-evaluative stress and daily functioning in first-episode schizophrenia
- 1 December 2018
- Published by Elsevier in Schizophrenia Research
- Vol. 202, 328-332
Family burden predicts functional outcome in the early course of schizophrenia beyond psychiatric symptoms and baseline functioning
- 1 December 2018
- Published by Elsevier in Schizophrenia Research
- Vol. 202, 328-332
Family burden predicts functional outcome in the early course of schizophrenia beyond psychiatric symptoms and baseline functioning
- 27 February 2018
- Published by Elsevier in Schizophrenia Research
- Vol. 199, 221-225
Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia
- 27 February 2018
- Published by Elsevier in Schizophrenia Research
- Vol. 199, 221-225
Temporal lobe thickness and verbal memory in first-degree relatives of individuals with schizophrenia
- Open Access
- 1 August 2015
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 72 (8) , 822-829
Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia
An earlier study1 found that nonadherence with oral risperidone strongly predicted the return of psychotic symptoms in patients with a first episode of schizophrenia. Oral antipsychotic medication requires daily recommitment to treatment, which is hampered by patients’ poor awareness of the need for continued treatment. Long-acting injectable antipsychotic medication has the potential to control psychotic symptoms substantially better than short-acting medication.2-4 However, randomized clinical trials (RCTs) of long-acting injectable antipsychotics have generally not been convincing in this regard.5-12 Long-acting injectable antipsychotics are typically not used in the period following a first psychotic episode, instead being reserved for patients with demonstrated medication nonadherence. Ironically, when adherent, patients with a recent onset of schizophrenia usually have a more robust response to antipsychotic medications. Thus, given their frequent nonadherence with oral antipsychotics, recent-onset patients may show the clearest advantages of treatment with long-acting injectable antipsychotics.
- 1 August 2015
- Published by American Medical Association (AMA) in JAMA Psychiatry
- Vol. 72 (8) , 822-829
Open AccessLong-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia
An earlier study1 found that nonadherence with oral risperidone strongly predicted the return of psychotic symptoms in patients with a first episode of schizophrenia. Oral antipsychotic medication requires daily recommitment to treatment, which is hampered by patients’ poor awareness of the need for continued treatment. Long-acting injectable antipsychotic medication has the potential to control psychotic symptoms substantially better than short-acting medication.2-4 However, randomized clinical trials (RCTs) of long-acting injectable antipsychotics have generally not been convincing in this regard.5-12 Long-acting injectable antipsychotics are typically not used in the period following a first psychotic episode, instead being reserved for patients with demonstrated medication nonadherence. Ironically, when adherent, patients with a recent onset of schizophrenia usually have a more robust response to antipsychotic medications. Thus, given their frequent nonadherence with oral antipsychotics, recent-onset patients may show the clearest advantages of treatment with long-acting injectable antipsychotics.